Menu

• Ask a Health Expert about ACUTE GRAFT VERSUS HOST DISEASE IN LIVER
• Post Your Side Effect related to ACUTE GRAFT VERSUS HOST DISEASE IN LIVER
• ACUTE GRAFT VERSUS HOST DISEASE IN LIVER and FDA Warnings
• ACUTE GRAFT VERSUS HOST DISEASE IN LIVER in Patients Wiki
• Report ACUTE GRAFT VERSUS HOST DISEASE IN LIVER in Drug Side Effect Survey

ACUTE GRAFT VERSUS HOST DISEASE IN LIVER side effect

What is ACUTE GRAFT VERSUS HOST DISEASE IN LIVER ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cidofovir Side Effects Report #5651778-0
Consumer or non-health professional from UNITED STATES reported CIDOFOVIR problem on Feb 29, 2008. Male patient, child 6 years of age, was diagnosed with burkitt's lymphoma and was treated with CIDOFOVIR. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, adenovirus infection, burkitt's lymphoma recurrent, coma, creutzfeldt-jakob disease, csf myelin basic protein increased, csf protein increased, demyelination, . CIDOFOVIR dosage: unknown. During the same period patient was treated with DOXORUBICIN, CARBOPLATIN, VINCRISTINE, IFOSAMIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE, METHOTREXATE, RITUXIMAB. Patient died.

Carboplatin Side Effects Report #5656165-7
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2008. Male patient, child 6 years of age, was diagnosed with burkitt's lymphoma and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, aphasia, ataxia, coma, demyelination, dysarthria, encephalopathy, myoclonus, . CARBOPLATIN dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN, METHOTREXATE, ETOPOSIDE, IFOSFAMIDE, CYCLOPHOSPHAMIDE, RITUXIMAB, CIDOFOVIR. Patient died.

Cancidas Side Effects Report #5668163-8
Physician from GERMANY reported CANCIDAS problem on Mar 10, 2008. Male patient, 35 years of age, was diagnosed with stem cell transplant and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, blood bilirubin increased, . CANCIDAS dosage: IV; 50 MG/QID. During the same period patient was treated with CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5672599-9
CARBOPLATIN problem was reported by a Physician from UNITED STATES on Mar 10, 2008. Male patient, child 6 years of age, was diagnosed with burkitt's lymphoma, prophylaxis against graft versus host disease and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, adenovirus infection, aphasia, ataxia, burkitt's lymphoma recurrent, coma, csf protein increased, demyelination, . CARBOPLATIN dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, DOXORUBICIN. Patient died.


Prednisone Side Effects Report #5678037-4
Health Professional from UNITED STATES reported PREDNISONE problem on Feb 27, 2008. Male patient, child 6 years of age, was diagnosed with burkitt's lymphoma, prophylaxis against graft versus host disease and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, adenovirus infection, burkitt's lymphoma recurrent, coma, demyelination, encephalopathy, gliosis, respiratory disorder, . PREDNISONE dosage: unknown. During the same period patient was treated with METHOTREXATE, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE, VINCRISTINE, RITUXIMAB. Patient died.

Cancidas Side Effects Report #5679235-6
CANCIDAS problem was reported by a Consumer or non-health professional from GERMANY on Mar 10, 2008. Male patient, 35 years of age, was diagnosed with stem cell transplant and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, blood bilirubin increased, . CANCIDAS dosage: 50 MG/QID IV. During the same period patient was treated with CYCLOSPORINE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5685271-6
Consumer or non-health professional from UNITED STATES reported DOXORUBICIN problem on Mar 19, 2008. Male patient, child 6 years of age, was diagnosed with burkitt's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, burkitt's lymphoma recurrent, coma, csf protein increased, encephalopathy, gliosis, mitochondrial cytopathy, progressive multifocal leukoencephalopathy, . DOXORUBICIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, CIDOFOVIR, ETOPOSIDE, VINCRISTINE, IFOSFAMIDE, CYCLOPHOSPHAMIDE, METHOTREXATE, RITUXIMAB. Patient died.

Fludarabine Side Effects Report #5618328-6
FLUDARABINE problem was reported by a Health Professional from SWEDEN on Jan 22, 2008. Male patient, 61 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, chronic graft versus host disease, genital lesion, lichenification, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULPHAN, CYCLOSPORINE, METHOTREXATE. Patient recovered.

Fludarabine Side Effects Report #5618724-7
Health Professional from SWEDEN reported FLUDARABINE problem on Jan 22, 2008. Male patient, 61 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, chronic graft versus host disease, genital lesion, lichenification, . FLUDARABINE dosage: unknown. During the same period patient was treated with BUSULPHAN, CYCLOSPORINE, METHOTREXATE. Patient recovered.


Clofarabine Side Effects Report #5627136-1
CLOFARABINE problem was reported by a Health Professional from UNITED STATES on Feb 12, 2008. Male patient was diagnosed with stem cell transplant and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, blood culture positive, . CLOFARABINE dosage: 84MG DAILY IV DRIP. During the same period patient was treated with MELPHALAN, CAMPATH. Patient died on 02/10/2008.

Fludarabine Side Effects Report #5580403-2
Health Professional from UNITED STATES reported FLUDARABINE PHOSPHATE problem on Dec 21, 2007. Female patient, 60 years of age, was diagnosed with mantle cell lymphoma, prophylaxis and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, aspergillosis, liver function test abnormal, neutropenia, renal impairment, sepsis syndrome, severe acute respiratory syndrome, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with RITUXIMAB, VORICONAZOLE, ANIDULAFUNGIN. Patient was hospitalized. Patient died.

Etoposide Side Effects Report #5535270-X
ETOPOSIDE problem was reported by a Physician from UNITED STATES on Nov 16, 2007. Male patient, 53 years of age, was diagnosed with graft versus host disease, chronic graft versus host disease and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, lip and/or oral cavity cancer, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYTARABINE, IDARABUCIN, CYCLOSPORINE, METHOTREXATE, CORTICOSTEROIDS. Patient recovered.

Prograf Side Effects Report #5542729-8
Physician from UNITED STATES reported PROGRAF problem on Nov 27, 2007. Female patient, 54 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, MYCOPHENOLATE MOFETIL, SIROLIMUS. Patient died.

Prograf Side Effects Report #5542913-3
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 27, 2007. Male patient, 26 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, arthropathy, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, HYDROXYCHLOROQUINE SULPHATE, SIROLIMUS, QUININE. Patient recovered.


Stem Side Effects Report #5563219-2
Health Professional from UNITED STATES reported STEM CELL problem on Dec 13, 2007. Male patient, 35 years of age, weighting 238.1 lb, was treated with STEM CELL. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, eye disorder, ill-defined disorder, pyrexia, . STEM CELL dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, PREDNISONE, CELLCEPT, GEFERASIROX, PYRIDOXINE, DIGOXIN, VALGANCICLOVIR, BACTRIM. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5504837-7
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on Oct 23, 2007. Female patient, 21 years of age, was diagnosed with bone marrow transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, albumin urine present, glomerulonephritis proliferative, glomerulosclerosis, hypercholesterolaemia, hypoalbuminaemia, hypoproteinaemia, nephrotic syndrome, proteinuria, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IMMUNOGLOBULIN, FLUOROURACIL. Patient recovered.

Methotrexate Side Effects Report #5525450-1
Physician from JAPAN reported METHOTREXATE problem on Nov 06, 2007. Female patient, 54 years of age, was diagnosed with prophylaxis against graft versus host disease, acute graft versus host disease, chronic myeloid leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, cerebral toxoplasmosis, chronic myeloid leukaemia, leukaemia recurrent, pneumonia bacterial, sepsis, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, IMATINIB, TRIMETHOPRIM, SULFAMETHOXAZOLE. Patient died.

Voriconazole Side Effects Report #5476799-2
VORICONAZOLE problem was reported by a Pharmacist from UNITED STATES on Oct 03, 2007. Male patient, 58 years of age, weighting 175.7 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with VORICONAZOLE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, cholestasis, fungal infection, hepatotoxicity, renal failure acute, . VORICONAZOLE dosage: 300MG Q12H IVPB. During the same period patient was treated with ACETAMINOPHEN, ADDERALL, BUMETANIDE, CEFEPIME, NEUPOGEN, MEGESTROL ACETATE, BACTRIM. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5486870-7
Consumer or non-health professional from UNITED STATES reported CYCLOSPORINE problem on Oct 12, 2007. Female patient, weighting 165.3 lb, was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, blood bilirubin increased, bradycardia, culture urine positive, disseminated cytomegaloviral infection, hypotension, pseudomonas infection, respiratory distress, respiratory failure, . CYCLOSPORINE dosage: 188 MG. During the same period patient was treated with METHOTREXATE, METHOXSALEN, CELLCEPT, PENTOSTATIN. Patient was hospitalized. Patient died on 10/03/2007.


Cyclosporine Side Effects Report #5487686-8
CYCLOSPORINE problem was reported by a Health Professional from UNITED STATES on Oct 10, 2007. Male patient, child 8 years of age, was diagnosed with stem cell transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, buccal polyp, chronic graft versus host disease, glossodynia, leukaemia recurrent, mouth ulceration, polypectomy, stem cell transplant, tongue disorder, . CYCLOSPORINE dosage: 5 MG/KG/D. During the same period patient was treated with PREDNISONE, AMPHOTERICIN B, AMLODIPINE, CLONIDINE, POTASSIUM CHLORIDE, MAGNESIUM SULPHATE, PHOSPHORUS, ALUMINUM HYDROXIDE GEL. Patient recovered.

Clofarabine Side Effects Report #5448443-1
Health Professional from UNITED STATES reported CLOFARABINE problem on Aug 29, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, bacteraemia, brain oedema, cardiac arrest, cystitis haemorrhagic, eye disorder, gastrointestinal disorder, hypotension, mental status changes, . CLOFARABINE dosage: 168.8 MG IV. During the same period patient was treated with BUSULFAN, FLUDARABINE PHOSPHATE. Patient was hospitalized. Patient died on 07/29/2007.

Clofarabine Side Effects Report #5467563-9
CLOFARABINE problem was reported by a Physician from UNITED STATES on Sept 19, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, bacteraemia, brain oedema, cardiac arrest, cystitis haemorrhagic, eye disorder, gastrointestinal disorder, . CLOFARABINE dosage: 168.8 MG IV. During the same period patient was treated with BUSULFAN, FLUDARABINE PHOSPHATE, ACTIGALL, AMLODIPINE BESYLATE, BACTRIM DS, BUDESONIDE, CIPRO, CLARITIN. Patient was hospitalized. Patient died on 07/29/2007.

Revlimid Side Effects Report #5762052-6
Physician from GERMANY reported REVLIMID problem on May 27, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with IMMUNE CELLS, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.

Prednisone Side Effects Report #5772956-6
PREDNISONE problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2008. Female patient, 20 years of age, was diagnosed with immunosuppression, acute lymphocytic leukaemia, prophylaxis against graft versus host disease and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, hepatic failure, hepatic neoplasm, hepatitis fulminant, herpes zoster disseminated, hyponatraemia, intestinal obstruction, . PREDNISONE dosage: 1 MG/KG. During the same period patient was treated with CYCLOPHOSPHAMIDE, TACROLIMUS, RAPAMYCIN. Patient was hospitalized. Patient died.

Cyclosporine Side Effects Report #5738624-1
Health Professional from JAPAN reported CYCLOSPORINE problem on May 05, 2008. Male patient, 65 years of age, was diagnosed with stem cell transplant, antiviral prophylaxis and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, adenoviral haemorrhagic cystitis, bacteraemia, cytomegalovirus infection, hepatitis b, herpes zoster, pericardial effusion, septic shock, . CYCLOSPORINE dosage: 3 MG/KG/DAY. During the same period patient was treated with METHOTREXATE, IMMUNOGLOBULINS, FILGRASTIM, ACYCLOVIR. Patient recovered.

Prograf Side Effects Report #5704606-9
PROGRAF problem was reported by a Physician from JAPAN on Mar 24, 2008. Male patient, 17 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, acute myeloid leukaemia recurrent, pancytopenia, stem cell transplant, . PROGRAF dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS. Patient died on 04/01/2005.

Carboplatin Side Effects Report #5708905-6
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on Apr 10, 2008. Male patient, child 6 years of age, was diagnosed with burkitt's lymphoma, prophylaxis against graft versus host disease and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, adenovirus infection, aphasia, ataxia, bone marrow transplant, coma, csf protein increased, demyelination, . CARBOPLATIN dosage: 50 MG IV. During the same period patient was treated with METHOTREXATE, VINCRISTINE, DOXORUBICIN. Patient died.

Prograf Side Effects Report #5319718-1
PROGRAF problem was reported by a Physician from JAPAN on Apr 16, 2007. Male patient, 58 years of age, weighting 159.8 lb, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, bone marrow transplant, bronchopulmonary aspergillosis, depressed level of consciousness, hepatic failure, human herpesvirus 6 infection, oral candidiasis, . PROGRAF dosage: unknown. During the same period patient was treated with ACYCLOVIR, TEICOPLANINECTION, MILLISROL, NOVOLIN R, FUNGUARD, FLUDARA, ALKERAN. Patient died on 01/06/2005.

Prograf Side Effects Report #5319748-X
Physician from JAPAN reported PROGRAF problem on Apr 16, 2007. Male patient, 58 years of age, weighting 159.8 lb, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, bronchopulmonary aspergillosis, depressed level of consciousness, hepatic failure, human herpesvirus 6 infection, liver disorder, oral candidiasis, . PROGRAF dosage: unknown. During the same period patient was treated with ACYCLOVIR, TEICOPLANINECTION, MILLISROL, NOVOLIN R, FLUDARA, ALKERAN. Patient died on 01/06/2005.

Revlimid Side Effects Report #5293883-7
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 29, 2007. Male patient, 57 years of age, was diagnosed with 5q-syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, asthenia, biopsy bone marrow normal, chills, chromosome abnormality, cryptogenic organising pneumonia, dyspnoea, marrow hyperplasia, . REVLIMID dosage: unknown. During the same period patient was treated with BACTRIM, ACYCLOVIR, PROGRAF, PREDNISONE, MAGNESIUM OXIDE, INDERAL LA. Patient was hospitalized. Patient died on 07/21/2006.

Prograf Side Effects Report #5306158-4
Physician from JAPAN reported PROGRAF problem on Mar 30, 2007. Male patient, 16 years of age, weighting 88.18 lb, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, genital herpes, herpes zoster, iritis, lacrimation increased, necrotising herpetic retinopathy, rash, retinal tear, . PROGRAF dosage: 0.35 MG, D. During the same period patient was treated with FUNGUARD, VALTREX, FOSCAVIR, CIDOFOVIR, DENOSINE, FIRSTCIN, VORICONAZOLE. Patient recovered.

Thalomid Side Effects Report #5307769-2
THALOMID problem was reported by a Physician from UNITED STATES on Apr 11, 2007. Male patient, 20 years of age, was diagnosed with acute graft versus host disease in skin and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in liver, blood glucose increased, blood magnesium increased, blood pressure increased, blood sodium decreased, blood urea increased, discomfort, enterococcal infection, fluid intake reduced, . THALOMID dosage: 400-800 MG, ORAL. During the same period patient was treated with DECADRON, ACTIGALL, ARANESP, PROCARDIA, COLACE, SENOKOT, LACTULOSE, VERSED. Patient was hospitalized. Patient died on 02/15/2003.

Busulfan Side Effects Report #5663700-1
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Feb 22, 2008. Male patient, 80 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, amnesia, angiopathy, bk virus infection, blood culture positive, blood pressure increased, bone marrow transplant, . BUSULFAN dosage: 30.68 ML;QD;IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, FILGRASTIM, METHOTREXATE, CYCLOSPORINE, VORICONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient was hospitalized. Patient died on 12/08/2007.

Prograf Side Effects Report #5671997-7
PROGRAF problem was reported by a Physician from JAPAN on Feb 28, 2008. Female patient, 39 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute graft versus host disease in liver, anxiety, gastrointestinal disorder, idiopathic pneumonia syndrome, jaundice, no therapeutic response, oral intake reduced, skin lesion, . PROGRAF dosage: unknown. During the same period patient was treated with ETANERCEPT, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE. Patient died.

Campath Side Effects Report #5627818-1
Physician from SPAIN reported CAMPATH problem on Feb 11, 2008. Male patient, 61 years of age, was diagnosed with acute graft versus host disease and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, fungal infection, . CAMPATH dosage: unknown. Patient was hospitalized. Patient died on 02/04/2008.

Cyclosporine Side Effects Report #5639007-5
CYCLOSPORINE problem was reported by a Health Professional from UNITED STATES on Feb 13, 2008. Female patient, child 12 years of age, was diagnosed with bone marrow transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cholestasis, chronic graft versus host disease, gamma-glutamyltransferase increased, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, FLUDARABINE, BUSULFAN, ANTITHYMOCYTE IMMUNOGLOBULIN, PREDNISONE. Patient died.

Prograf Side Effects Report #5535044-X
Physician from UNITED STATES reported PROGRAF problem on Nov 15, 2007. Male patient, 55 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, condition aggravated, encephalopathy, haemolytic anaemia, headache, influenza like illness, . PROGRAF dosage: 1 MG, UID/QD. Patient recovered.

Alemtuzumab Side Effects Report #5537517-2
ALEMTUZUMAB problem was reported by a Health Professional from UNITED STATES on Nov 21, 2007. Male patient, 55 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, cough, dyspnoea, encephalopathy, haemolytic anaemia, headache, . ALEMTUZUMAB dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, TACROLIMUS. Patient recovered.

Cyclosporine Side Effects Report #5557404-3
Physician from PORTUGAL reported CYCLOSPORINE problem on Nov 27, 2007. Male patient, 53 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, acute graft versus host disease in liver, acute graft versus host disease in skin, anaemia, autoimmune disorder, cholestasis, cytomegalovirus infection, diplopia, dry eye, . CYCLOSPORINE dosage: 50 MG, Q12H,. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, FLUDARABINE PHOSPHATE, BUSULFAN, ENALAPRIL MALEATE, BISOPROLOL FUMARATE, SULFAMETHOXAZOLE W, ACYCLOVIR. Patient was hospitalized. Patient recovered.

Alemtuzumab Side Effects Report #5558177-0
ALEMTUZUMAB problem was reported by a Health Professional from UNITED STATES on Nov 21, 2007. Male patient, 55 years of age, was diagnosed with bone marrow conditioning regimen, prophylaxis against graft versus host disease and was treated with ALEMTUZUMAB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, cough, dyspnoea, encephalopathy, haemolytic anaemia, headache, . ALEMTUZUMAB dosage: TOTAL DAILY DOSE: 10 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, TACROLIMUS. Patient recovered.

Imatinib Side Effects Report #5474054-8
Physician from FRANCE reported IMATINIB problem on Sept 25, 2007. Male patient, 39 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, acute respiratory distress syndrome, adenovirus infection, aptyalism, bacteria stool identified, bronchopulmonary aspergillosis, c-reactive protein increased, . IMATINIB dosage: 400 MG, QD. During the same period patient was treated with HYPER. Patient was hospitalized. Patient died on 09/03/2007.

Clofarabine Side Effects Report #5475351-2
CLOFARABINE problem was reported by a Physician from UNITED STATES on Sept 25, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, bacteraemia, brain oedema, cardiac arrest, cystitis haemorrhagic, eye disorder, . CLOFARABINE dosage: 168.8 MG IV. During the same period patient was treated with BUSULFAN, FLUDARABINE PHOSPHATE, ACTIGALL, AMLODIPINE BESYLATE, BACTRIM, BUDESONIDE, CIPRO, CLARITIN. Patient was hospitalized. Patient died on 07/29/2007.

Imatinib Side Effects Report #5482093-6
Physician from FRANCE reported IMATINIB problem on Oct 05, 2007. Male patient, 39 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, acute respiratory distress syndrome, adenovirus infection, aptyalism, bacteria stool identified, bronchopulmonary aspergillosis, c-reactive protein increased, . IMATINIB dosage: 400 MG, QD. During the same period patient was treated with HYPER. Patient was hospitalized. Patient died on 09/03/2007.

Thymoglobulin Side Effects Report #5489006-1
THYMOGLOBULIN problem was reported by a Physician from GERMANY on Sept 21, 2007. Male patient, 49 years of age, weighting 176.4 lb, was diagnosed with graft versus host disease and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, bone marrow failure, cardiac failure, condition aggravated, gastrointestinal haemorrhage, pneumonia, . THYMOGLOBULIN dosage: 80 MG QD IV. During the same period patient was treated with CANCIDAS, ROCEPHIN, DOXYCYCLINE, COTRIM, ACYCLOVIR, PENTAGLOBIN. Patient died on 09/19/2007.

Cgp Side Effects Report #5447200-X
Physician from FRANCE reported CGP problem on Sept 05, 2007. Male patient, 49 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CGP. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, acute respiratory distress syndrome, adenovirus infection, aptyalism, bacteria stool identified, bronchopulmonary aspergillosis, c-reactive protein increased, . CGP dosage: 400 MG, QD. During the same period patient was treated with HYPER. Patient was hospitalized. Patient died on 09/03/2007.

Aranesp Side Effects Report #5377446-0
ARANESP problem was reported by a Physician from UNITED STATES on June 22, 2007. Female patient, 55 years of age, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, anaemia, surgical procedure repeated, transplant, transplant failure, viral infection, . ARANESP dosage: unknown. During the same period patient was treated with TACROLIMUS, IMMUNOSUPPRESSANTS, ANTIBIOTIC NOS. Patient was hospitalized. Patient died.

Aranesp Side Effects Report #5377446-0
Physician from UNITED STATES reported ARANESP problem on June 22, 2007. Female patient, 55 years of age, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, anaemia, surgical procedure repeated, transplant, transplant failure, viral infection, . ARANESP dosage: unknown. During the same period patient was treated with TACROLIMUS, IMMUNOSUPPRESSANTS, ANTIBIOTIC NOS. Patient was hospitalized. Patient died.

Busulfex Side Effects Report #5767263-1
BUSULFEX problem was reported by a Consumer or non-health professional from FRANCE on May 27, 2008. Male patient, 51 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, thrombotic microangiopathy, . BUSULFEX dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, METHOTREXATE. Patient died.

Busulfex Side Effects Report #5767661-6
Consumer or non-health professional from ISRAEL reported BUSULFEX problem on May 27, 2008. Male patient, 37 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute graft versus host disease in skin, cerebral haemorrhage, no therapeutic response, thrombotic microangiopathy, . BUSULFEX dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, CYCLOSPORINE, METHOTREXATE. Patient was hospitalized. Patient died.

Busulfex Side Effects Report #5767667-7
BUSULFEX problem was reported by a Consumer or non-health professional from JAPAN on May 27, 2008. Female patient, 50 years of age, was diagnosed with stem cell transplant and was treated with BUSULFEX. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in intestine, acute graft versus host disease in liver, acute respiratory distress syndrome, aspergillosis, encephalitis, engraftment syndrome, lymphoma, thrombotic thrombocytopenic purpura, . BUSULFEX dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IMMUNOGLOBULIN. Patient was hospitalized. Patient died.